Skip to main content
. 2012 Jan 16;35(2):218–225. doi: 10.2337/dc11-1109

Table 2.

Effect of treatment on primary and secondary outcomes by baseline eGFR

graphic file with name 218tbl2.jpg

HHS Vulnerability Disclosure